Idorsia Ltd (SWX:IDIA)
Switzerland · Delayed Price · Currency is CHF 4.060
-0.066 (-1.60%)
Nov 11, 2026, 12:59 PM CET
Idorsia Market Cap
Idorsia has a market cap or net worth of 1.1 billion as of November 10, 2026. It is the 8,441st most valuable company in the world and the 115th biggest in Switzerland. Its market cap has increased by 41.02% in one year.
Market Cap
1.10B
Enterprise Value
2.34B
Revenue
220.15M
Global Rank
Country Rank
#115 Switzerland
PE Ratio
n/a
ChartMarket Cap Chart
Since June 16, 2017, Idorsia's market cap has decreased from 1.63B to 1.10B, a decrease of -32.64%. That is a compound annual growth rate of -4.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 1.10B | 3.07% |
| Dec 30, 2025 | 1.06B | 586.49% |
| Dec 30, 2024 | 154.81M | -58.92% |
| Dec 29, 2023 | 376.84M | -84.18% |
| Dec 30, 2022 | 2.38B | -27.77% |
| Dec 30, 2021 | 3.30B | -22.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.97B |
| Basilea Pharmaceutica AG | 884.74M |
| Santhera Pharmaceuticals Holding AG | 228.69M |
| Newron Pharmaceuticals | 194.97M |
| BioVersys AG | 137.84M |
| Molecular Partners AG | 98.91M |
| Xlife Sciences AG | 47.87M |
| MindMaze Therapeutics Holding | 23.46M |